119 related articles for article (PubMed ID: 12008748)
1. Twenty-four hour 17-hydroxyprogesterone response to adrenocorticotropine in adrenal incidentalomas: augmented response after adrenalectomy in two patients.
Kamel N; Erdoğan MF; Tonyukuk V; Ilgin SD; Erdoğan G
Endocr J; 2002 Feb; 49(1):35-40. PubMed ID: 12008748
[TBL] [Abstract][Full Text] [Related]
2. Adrenal incidentaloma: an overview of hormonal data from the National Italian Study Group.
Mantero F; Masini AM; Opocher G; Giovagnetti M; Arnaldi G
Horm Res; 1997; 47(4-6):284-9. PubMed ID: 9167966
[TBL] [Abstract][Full Text] [Related]
3. 17-Hydroxyprogesterone response to ACTH in bilateral and monolateral adrenal incidentalomas.
Bernini GP; Brogi G; Vivaldi MS; Argenio GF; Sgrò M; Moretti A; Salvetti A
J Endocrinol Invest; 1996 Dec; 19(11):745-52. PubMed ID: 9061508
[TBL] [Abstract][Full Text] [Related]
4. Alterations in hypothalamic-pituitary-adrenal function immediately after resection of adrenal adenomas in patients with Cushing's syndrome and others with incidentalomas and subclinical hypercortisolism.
Khawandanah D; ElAsmar N; Arafah BM
Endocrine; 2019 Jan; 63(1):140-148. PubMed ID: 30259310
[TBL] [Abstract][Full Text] [Related]
5. Low basal androstenedione levels plus augmented 17alpha-hydroxyprogesterone and low dehydroepiandrosterone sulfate responses to adrenocorticotropic hormone stimulation in patients with adrenal incidentaloma.
Ozgen AG; Bayraktar F; Yilmaz C
Endocr Pract; 2001; 7(6):448-53. PubMed ID: 11747281
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of dehydroepiandrosterone sulfate in patients with asymptomatic cortisol producing adrenal adenoma: comparison with adrenal Cushing's syndrome and non-functional adrenal tumor.
Morio H; Terano T; Yamamoto K; Tomizuka T; Oeda T; Saito Y; Tamura Y; Sasano H
Endocr J; 1996 Aug; 43(4):387-96. PubMed ID: 8930526
[TBL] [Abstract][Full Text] [Related]
7. Increased 17 alpha-hydroxyprogesterone response to ACTH in silent adrenal adenoma: cause or effect?
Del Monte P; Bernasconi D; Bertolazzi L; Meozzi M; Badaracco B; Torre R; Marugo M
Clin Endocrinol (Oxf); 1995 Mar; 42(3):273-7. PubMed ID: 7758232
[TBL] [Abstract][Full Text] [Related]
8. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
[TBL] [Abstract][Full Text] [Related]
9. Coexistence of 21-hydroxylase and 11 beta-hydroxylase deficiency in adrenal incidentalomas and in subclinical Cushing's syndrome.
Dall'Asta C; Barbetta L; Libé R; Passini E; Ambrosi B
Horm Res; 2002; 57(5-6):192-6. PubMed ID: 12053092
[TBL] [Abstract][Full Text] [Related]
10. Incidental adrenal nodules: association with exaggerated 17-hydroxyprogesterone response to adrenocorticotropic hormone.
Turton DB; O'Brian JT; Shakir KM
J Endocrinol Invest; 1992 Dec; 15(11):789-96. PubMed ID: 1337905
[TBL] [Abstract][Full Text] [Related]
11. Increased adrenal steroid secretion in response to CRF in women with hypothalamic amenorrhea.
Genazzani AD; Bersi C; Luisi S; Fruzzetti F; Malavasi B; Luisi M; Petraglia F; Genazzani AR
J Steroid Biochem Mol Biol; 2001 Sep; 78(3):247-52. PubMed ID: 11595505
[TBL] [Abstract][Full Text] [Related]
12. Augmented 17 alpha-hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21-hydroxylase activity in patients with incidentally discovered adrenal tumours ('incidentalomas').
Seppel T; Schlaghecke R
Clin Endocrinol (Oxf); 1994 Oct; 41(4):445-51. PubMed ID: 7955456
[TBL] [Abstract][Full Text] [Related]
13. Hormonal evaluation and mutation screening for steroid 21-hydroxylase deficiency in patients with unilateral and bilateral adrenal incidentalomas.
Patócs A; Tóth M; Barta C; Sasvári-Székely M; Varga I; Szücs N; Jakab C; Gláz E; Rácz K
Eur J Endocrinol; 2002 Sep; 147(3):349-55. PubMed ID: 12213672
[TBL] [Abstract][Full Text] [Related]
14. Pituitary-adrenocortical function in abdominal obesity of males: evidence for decreased 21-hydroxylase activity.
Hautanen A; Adlercreutz H
J Steroid Biochem Mol Biol; 1996 Apr; 58(1):123-33. PubMed ID: 8809194
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of plasma 17-hydroxyprogesterone and cortisol responses to ACTH in patients with various adrenal tumors before and after unilateral adrenalectomy.
Tóth M; Rácz K; Adleff V; Varga I; Fütö L; Jakab C; Karlinger K; Kiss R; Gláz E
J Endocrinol Invest; 2000 May; 23(5):287-94. PubMed ID: 10882146
[TBL] [Abstract][Full Text] [Related]
16. Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas).
Osella G; Terzolo M; Borretta G; Magro G; Alí A; Piovesan A; Paccotti P; Angeli A
J Clin Endocrinol Metab; 1994 Dec; 79(6):1532-9. PubMed ID: 7989452
[TBL] [Abstract][Full Text] [Related]
17. 17-Hydroxyprogesterone responses to adrenocorticotropin in children with premature adrenarche.
Granoff AB; Chasalow FI; Blethen SL
J Clin Endocrinol Metab; 1985 Mar; 60(3):409-15. PubMed ID: 2982895
[TBL] [Abstract][Full Text] [Related]
18. A comparison between the effects of low dose (1 microg) and standard dose (250 microg) ACTH stimulation tests on adrenal P450c17alpha enzyme activity in women with polycystic ovary syndrome.
Colak R; Keleştimur F; Unlühizarci K; Bayram F; Sahin Y; Tutuş A
Eur J Endocrinol; 2002 Oct; 147(4):473-7. PubMed ID: 12370108
[TBL] [Abstract][Full Text] [Related]
19. Dissociated recovery of cortisol and dehydroepiandrosterone sulphate after treatment for Cushing's syndrome.
Kleiber H; Rey F; Temler E; Gomez F
J Endocrinol Invest; 1991 Jun; 14(6):489-92. PubMed ID: 1663528
[TBL] [Abstract][Full Text] [Related]
20. Value of buserelin testing in the evaluation of hirsute women.
Ambrosi B; Re T; Passini E; Bochicchio D; Ferrario R
J Endocrinol Invest; 1996 Apr; 19(4):204-9. PubMed ID: 8862498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
